Cargando…

Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma

Long non-coding RNAs (lncRNAs) comprise an integral part of the eukaryotic transcriptome. Alongside proteins, lncRNAs modulate lncRNA-based gene signatures of unstable transcripts, play a crucial role as antisense lncRNAs to control intracellular homeostasis and are implicated in tumorigenesis. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maimaiti, Aierpati, Wang, Xixian, Pei, Yinan, Nuermaimaiti, Nuerbiye, Tuersunniyazi, Abudireheman, Abula, Yaeraili, Feng, Zhaohai, Jiang, Lei, Shi, Xin, Kasimu, Maimaitijiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221298/ https://www.ncbi.nlm.nih.gov/pubmed/34081618 http://dx.doi.org/10.18632/aging.203079

Ejemplares similares

N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2023)

Modification Patterns of DNA Methylation-Related lncRNAs Regulating Genomic Instability for Improving the Clinical Outcomes and Tumour Microenvironment Characterisation of Lower-Grade Gliomas
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

The Role of the Three-Dimensional Edge-Enhancing Gradient Echo Sequence at 3T MRI in the Detection of Focal Cortical Dysplasia: A Technical Case Report and Literature Review
por: Abula, Yaeraili, et al.
Publicado: (2022)

CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma
por: Mijiti, Maimaitili, et al.
Publicado: (2023)

Identification of VASH1 as a Potential Prognostic Biomarker of Lower-Grade Glioma by Quantitative Proteomics and Experimental Verification
por: Aili, Yirizhati, et al.
Publicado: (2022)

Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma
por: Qin, Hu, et al.
Publicado: (2023)

Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
por: Gallus, Marco, et al.
Publicado: (2023)

Effects of Periostracum Cicadae on Cytokines and Apoptosis Regulatory Proteins in an IgA Nephropathy Rat Model
por: Yang, Lu, et al.
Publicado: (2018)

Staufen1 unwinds the secondary structure and facilitates the translation of fatty acid binding protein 4 mRNA during adipogenesis
por: Liang, Xiaodi, et al.
Publicado: (2021)

Identification of a Tumor Microenvironment-Related Eight-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas
por: Su, Jun, et al.
Publicado: (2019)

Multi-Omics Analysis Based on Genomic Instability for Prognostic Prediction in Lower-Grade Glioma
por: Cao, Yudong, et al.
Publicado: (2022)

Genomic instability in lower-grade glioma: Prediction of prognosis based on lncRNA and immune infiltration
por: Kang, Kai, et al.
Publicado: (2021)

MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma
por: Molloy, Abigail R, et al.
Publicado: (2020)

Adenovirus type 36 regulates adipose stem cell differentiation and glucolipid metabolism through the PI3K/Akt/FoxO1/PPARγ signaling pathway
por: Jiao, Yi, et al.
Publicado: (2019)

Genome Instability-Associated Long Non-Coding RNAs Reveal Biomarkers for Glioma Immunotherapy and Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2022)

Microsatellite Instability in Pediatric High Grade Glioma Is Associated with Genomic Profile and Differential Target Gene Inactivation
por: Viana-Pereira, Marta, et al.
Publicado: (2011)

Adenovirus36 infection expresses cellular APMI and Visfatin genes in overweight Uygur individuals
por: Jiao, Yi, et al.
Publicado: (2014)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Methylation of PD-1 Promoter Gene as New Prognostic Marker for IDH Mutant Low-Grade Glioma?
por: Marosi, Christine
Publicado: (2018)

5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma
por: Glowacka, Wioletta K., et al.
Publicado: (2018)

Duchenne muscular dystrophy gene expression is an independent prognostic marker for IDH mutant low-grade glioma
por: Naidoo, Michael, et al.
Publicado: (2022)

MPC-2 Clinical course and prognosis of lower-grade glioma, IDH wildtype and pTERT mutant
por: Takahashi, Yoshinobu, et al.
Publicado: (2021)

A Qualitative Signature to Identify TERT Promoter Mutant High-Risk Tumors in Low-Grade Gliomas
por: Zheng, Weicheng, et al.
Publicado: (2022)

Starch Properties and Morphology of Eight Floury Endosperm Mutants in Rice
por: Hao, Yuanyuan, et al.
Publicado: (2023)

Regulatory effect of chemerin and therapeutic efficacy of chemerin-9 in pancreatogenic diabetes mellitus
por: Tu, Jianfeng, et al.
Publicado: (2020)

High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China
por: Maimaiti, Rena, et al.
Publicado: (2017)

Efficacy of (11)C-2β-carbomethoxy-3β-(4-fluorophenyl) tropane positron emission tomography combined with (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis of early Parkinson disease: A protocol for systematic review and meta analysis
por: Jiang, Lei, et al.
Publicado: (2020)

Dynamic Interplay between Lower-Grade Glioma Instability and Brain Metaplasticity: Proposal of an Original Model to Guide the Therapeutic Strategy
por: Duffau, Hugues
Publicado: (2021)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Management of traumatic atlanto-axial instability: A retrospective study of eight cases
por: Shetty, Arjun, et al.
Publicado: (2012)

An Immune-Related Prognostic Signature for Predicting Clinical Outcomes and Immune Landscape in IDH-Mutant Lower-Grade Gliomas
por: Xiao, Gang, et al.
Publicado: (2021)

Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study
por: Sagberg, Lisa Millgård, et al.
Publicado: (2022)

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
por: Mellinghoff, Ingo K., et al.
Publicado: (2023)

Efficacy and Safety of Trametinib Monotherapy or in Combination With Dabrafenib in Pediatric BRAF V600–Mutant Low-Grade Glioma
por: Bouffet, Eric, et al.
Publicado: (2023)

BIOL-13. DEPLOYING NEW MODELS OF NF-1 MUTANT LOW GRADE GLIOMA TO ACCELERATE THERAPEUTIC DEVELOPMENT
por: Alaali, Lujain, et al.
Publicado: (2023)

A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma
por: Feng, Qinglin, et al.
Publicado: (2021)

Chromosomal instability in adult-type diffuse gliomas
por: Richardson, Timothy E., et al.
Publicado: (2022)

Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989)

Chemotherapy for high-grade gliomas
por: Galanis, E, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_2596f0vquordki0aevrgv04k7h